Table 4:
Allogenic RBC transfusion (total) | Number of Patients (%) |
---|---|
Patients (%) | 14 (34%)† |
Units | 25 |
Allogenic RBC transfusion (intraoperative) | |
Patients (%) | 2 (5%) |
Units | 6 |
Median length of stay, days (range) | 8 (3 – 29) |
30-day complications (%) | |
Any grade | 29 (71%) |
≥ grade 3 | 8 (20%) † |
Anastomotic leak | 2 of 28 (7%) † |
RBC, red blood cell
Endpoint below predetermined thresholds for safety and efficacy